Evidence map›Paper›PMID 24005891›Full record

ArticleActa neuropathologica2013

Deep sequencing reveals increased DNA methylation in chronic rat epilepsy.

Katja Kobow, Antony Kaspi, K N Harikrishnan, Katharina Kiese, Mark Ziemann, Ishant Khurana, Ina Fritzsche, Jan Hauke, Eric Hahnen, Roland Coras and 3 more

Registry-linked trialOpen access · hybridAbstract read
In one paragraph

Article in Acta neuropathologica, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT02261753 (A Randomised Controlled Trial to Compare Seizure Remission Outcome Following Resective Surgery With or Without Prior Treatment With Ketogenic Diet in Children With Epilepsy the Result of Focal Cortical Dysplasia Type II), which is not on this map. Cited by 116 papers.

0numbers the graph read from it
0cells of the map it votes in
116citing papers in PubMed
7.6field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT02261753 naterminatednot on this mapstarted 2014, after this paper: background citation

A Randomised Controlled Trial to Compare Seizure Remission Outcome Following Resective Surgery With or Without Prior Treatment With Ketogenic Diet in Children With Epilepsy the Result of Focal Cortical Dysplasia Type II

TypeinterventionalSponsorUniversity College, LondonRan2014 to 2017Enrolled3ConditionsCortical DysplasiaArmsClassical ketogenic diet
3 · Its place in the literature

Who cites it

116 citing papers in PubMed, 205 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Review
  6. Review
  7. Article
  8. Article
  9. Review
  10. Review
  11. Article
  12. Adenosine Kinase: An Epigenetic Modulator and Drug Target.Journal of inherited metabolic disease · 2025
    Review
  13. Article
  14. Review
  15. Review
  16. Review
  17. Neuroglia and brain energy metabolism.Handbook of clinical neurology · 2025
    Review
  18. Article
  19. Article
  20. Review

56 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 6 institutions in 3 countries.

Katja KobowDepartment of Neuropathology, University Hospital Erlangen, Schwabachanlage 6, 91054, Erlangen, Germany, katja.kobow@uk-erlangen.de.
Antony Kaspi
K N Harikrishnan
Katharina Kiese
Mark Ziemann
Ishant Khurana
Ina Fritzsche
Jan Hauke
Eric Hahnen
Roland Coras
Angelika Mühlebner
Assam El-Osta
Ingmar Blümcke
Universitätsklinikum Erlangen · DEThe Alfred Hospital · AUBaker Heart and Diabetes Institute · AUMedical University of Vienna · ATUniversity Hospital Cologne · DEUniversity of Cologne · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Epilepsy is a frequent neurological disorder, although onset and progression of seizures remain difficult to predict in affected patients, irrespective of their epileptogenic condition. Previous studies in animal models as well as human epileptic brain tissue revealed a remarkably diverse pattern of gene expression implicating epigenetic changes to contribute to disease progression. Here we mapped for the first time global DNA methylation patterns in chronic epileptic rats and controls. Using methyl-CpG capture associated with massive parallel sequencing (Methyl-Seq) we report the genomic methylation signature of the chronic epileptic state. We observed a predominant increase, rather than loss of DNA methylation in chronic rat epilepsy. Aberrant methylation patterns were inversely correlated with gene expression changes using mRNA sequencing from same animals and tissue specimens. Administration of a ketogenic, high-fat, low-carbohydrate diet attenuated seizure progression and ameliorated DNA methylation mediated changes in gene expression. This is the first report of unsupervised clustering of an epigenetic mark being used in epilepsy research to separate epileptic from non-epileptic animals as well as from animals receiving anti-convulsive dietary treatment. We further discuss the potential impact of epigenetic changes as a pathogenic mechanism of epileptogenesis.

Indexed as

TranscriptomeAnimalsDiet, KetogenicDisease Models, AnimalDNA MethylationEpigenesis, GeneticEpilepsyHigh-Throughput Nucleotide SequencingMaleRatsRats, Wistar

Identifiers

PMID24005891
PMCPMC3825532
OpenAlexW1999380027

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.